Journal profile · Medicine-Oncology
Endocrine Oncology
ISSN 2634-4793 · Bioscientifica · United Kingdom
Endocrine Oncology: fully open access; APC about USD 2,700; median 141 days to acceptance (96 articles, last 24 months); 55 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Endocrine Oncology is published by Bioscientifica. By OpenAlex counts of its recent articles, its largest topics are Neuroendocrine Tumor Research Advances, Pituitary Gland Disorders and Treatments and Adrenal and Paraganglionic Tumors, together about 43.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endocrine Oncology is an official journal of the Society for Endocrinology. Endocrine Oncology is an open-access, peer-reviewed journal publishing basic, translational and clinical research and reviews on the interplay between hormones and cancer, and related topics. Endocrine Oncology will consider for publication all articles which contribute to the advancement of the field and are scientifically sound. Topics include, but are not limited to: Neuroendocrine tumours Adrenal tumours Pituitary tumours Breast tumours Prostate tumours Thyroid tumours Gynecological tumours Pancreatic tumours Parathyroid tumours Bone tumours Pheochromocytoma/paraganglioma Multiple endocrine neoplasia The interplay of diabetes, obesity, metabolism and cancer Endocrine Oncology encourages studies focusing on methodological and technical advances including bio-computational approaches, genomics, proteomics and transcriptomics. Clinical studies and proof of concepts are also welcome, along with translational studies in the development of novel therapies. Articles are published continuously, with one volume per year.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Justo P CastañoPublisher website
Editorial board by country: none in mainland China; most named Italy 8, United States 7, United Kingdom 7, Australia 6, Spain 5 (58 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroendocrine Tumor Research AdvancesMedicine21.6%
- Pituitary Gland Disorders and TreatmentsMedicine11.6%
- Adrenal and Paraganglionic TumorsMedicine10.5%
- Thyroid Cancer Diagnosis and TreatmentMedicine7.7%
- Thyroid and Parathyroid SurgeryMedicine6.4%
- Radiopharmaceutical Chemistry and ApplicationsMedicine4.1%
- Prostate Cancer Treatment and ResearchMedicine3.9%
- Adrenal Hormones and DisordersMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q4 | 343/428 | — |
| Endocrinology, Diabetes and Metabolism | Q4 | 204/250 | — |
| Cancer Research | Q4 | 204/233 | — |
| Endocrinology | Q4 | 121/132 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1LetPub ·
- CiteScore (publisher) 2025
- 1Publisher website ·
- SJR 2026-06
- 0.4LetPub ·
- SNIP 2026-06
- 0.49LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 14OpenAlex ·
- 2-year mean citedness
- 0.93OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 169 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 39 | 153 |
| 2025 | 55 | 55 | 172 |
| 2024 | 23 | 23 | 122 |
| 2023 | 18 | 18 | 31 |
| 2022 | 25 | 25 | 8 |
| 2021 | 9 | 9 | 2 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
141 daysMedian, submission to acceptance · P25–P75 103 days – 205 days
- Acceptance to online
- median 17 days (96 articles)
- Submission to online
- median 159 days
- Sample
- 96 articles with submission and acceptance dates (98 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 26 weeksLetPub ·
- Submission to publication (journal-reported)
- about 26 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 2,000 / EUR 2,300 / USD 2,700 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| LetPub | No APC | No | — | |
| Publisher website | GBP 2,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted14, with length limits
- brief reportch highlight expertise within the field Brief Reports These are reports, with up to 1500 words and 1 table or figure, and which report an important messagmain text ≤ 1,500 words
- case reportCase Reports can present a case study, case report, or other description of a case. Submissions can be based on a single case or a number of similar cases. Case…Length not stated
- commentaryCommentaries are typically invited by the Editor-in-Chief, although unsolicited commentaries will be considered. Commentaries are opinion articles that will exa…main text ≤ 2,500 words
- editorialthe editorial office as outlined below. Editorials All Editorials must be a maximum 1500 words (including references, legends and tables) and 10 referencemain text ≤ 1,500 words · references ≤ 10
- editorialsAll Editorials must be a maximum 1500 words (including references, legends and tables) and 10 references.Length not stated
- full articleResearch papers Manuscripts should be limited to 5000 words and contain no more than 10 figures/tables and no more than approximately 60 references. All researc…Length not stated
- hypothesisResearch papers Manuscripts should be limited to 5000 words and contain no more than 10 figures/tables and no more than approximately 60 references. All researc…Length not stated
- letters to the editorre of broad interest to the readership. Letters to the Editor can be no longer than 1500 words, have no abstract, have no more than 10 references and havemain text ≤ 1,500 words · figures and tables ≤ 2 · references ≤ 10
- mini reviewbe suitable for a full review article. Mini Reviews should be no more than 3000 words in length, with limited references and figures. We recommenmain text ≤ 3,000 words
- mini reviewsMini Reviews should be no more than 3000 words in length, with limited references and figures.Length not stated
- research paperResearch papers Manuscripts should be limited to 5000 words and contain no more than 10 figures/tables and no more than approximately 60 references. All researc…main text ≤ 5,000 words
- research papersResearch papers Manuscripts should be limited to 5000 words and contain no more than 10 figures/tables and no more than approximately 60 references.Length not stated
- review‘Manuscript Preparation’ section above. Review submissions should be limited to 6000 words. We recommend a maximum of 60 references for review articlemain text ≤ 6,000 words · figures and tables ≤ 6 · references ≤ 60
- reviewsReview submissions should be limited to 6000 words.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship
ORCID iD required for submitting authors; corresponding authors must create/link ORCID prior to acceptance. Model summary
All submitting authors are required to link their ScholarOne account with their ORCID iD.
Source ↗Publisher website ·- Conflicts of interest 7. Declaration of interest, Funding, Contributions and Acknowledgements
Declaration of interest Actual or perceived conflicts of interest for all authors must be declared in full. Please either (a) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or (b) fully declare any financial or other potential conflict of interest. Conflicts of interest include, but are not limited to: Employment and …
Source ↗Publisher website ·- Publication ethics
Human subjects research must comply with Declaration of Helsinki; consent statements required. Model summary
Authors must ensure research involving human subjects complies with the Declaration of Helsinki.
Source ↗Publisher website ·- License & copyright Licence and Copyright
During the submission process the submitting author will need to complete a publication agreement on behalf of the co-authors and the copyright holder for the article. As part of this agreement, the copyright holder will grant Bioscientifica a non-exclusive licence to publish the article. The copyright is retained by the original copyright holder and is not assigned to Bioscientifica. Authors may …
Source ↗Publisher website ·- Open access Open Access
Information on APCs, funder compliance, and your open access options. Read more about Open Access
Source ↗Publisher website ·- Peer review Peer Review Process
Single anonymous peer review; identity of reviewers and editors not disclosed to authors. Model summary
From editorial screening to final decisions, explore our peer review process, including appeals and transfers. Read more about the Peer Review Process
Source ↗Publisher website ·- Preprints Preprint repositories
A preprint is a version of the article prior to submission to the journal for peer review, and has not been copyedited or typeset. Bioscientifica allows deposition of preprints to recognised repositories, such as bioRxiv, provided that Bioscientifica is informed of this at the time of submission and it does not infringe any subsequent copyright or licence agreement. Upon final publication, authors…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Bioscientifica
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2634-4793
- Society / sponsor
- Society for Endocrinology
- Latest issue on the website
- Volume 6, Issue 1 (January 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Endocrine Oncology
How long does peer review take at Endocrine Oncology?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 141 days (interquartile range 103–205 days); authors report an average review time of about 26 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Endocrine Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 4; Manuscript length: ≤ 5,000 words; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Endocrine Oncology based?
Of the 58 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (8), United States (7) and United Kingdom (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrine Oncology?
According to LetPub and DOAJ records, Endocrine Oncology is indexed in Scopus and DOAJ.
Is Endocrine Oncology open access, and what is the APC?
Endocrine Oncology is a fully open-access journal. APC about USD 2,700.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .